Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma

Overview of attention for article published in Journal of Clinical Oncology, September 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

news: 7 news outlets
blogs: 2 blogs

twitter: 68 X users
guideline: 3 clinical guideline sources

Readers on

mendeley: 215 Mendeley

So far, Altmetric has seen 76 X posts from 68 X users, with an upper bound of 262,640 followers.

Together with @motzermd and @MVossMD we analyzed transcriptomic and IHC data from the placebo arm of the PROTECT trial (https://t.co/0rFqJHI4Ah) to identify determinants of metastasis.

New2Trip: Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients w/ Loc… https://t.co/zh0ep2uKeC

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 72 additional X posts.